IBDEI21K ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35670,0)
 ;;=I10.^^189^2060^21
 ;;^UTILITY(U,$J,358.3,35670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35670,1,3,0)
 ;;=3^Essential (primary) hypertension
 ;;^UTILITY(U,$J,358.3,35670,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,35670,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,35671,0)
 ;;=G89.29^^189^2060^12
 ;;^UTILITY(U,$J,358.3,35671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35671,1,3,0)
 ;;=3^Chronic Pain NEC
 ;;^UTILITY(U,$J,358.3,35671,1,4,0)
 ;;=4^G89.29
 ;;^UTILITY(U,$J,358.3,35671,2)
 ;;=^5004158
 ;;^UTILITY(U,$J,358.3,35672,0)
 ;;=F41.9^^189^2060^8
 ;;^UTILITY(U,$J,358.3,35672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35672,1,3,0)
 ;;=3^Anxiety disorder, unspecified
 ;;^UTILITY(U,$J,358.3,35672,1,4,0)
 ;;=4^F41.9
 ;;^UTILITY(U,$J,358.3,35672,2)
 ;;=^5003567
 ;;^UTILITY(U,$J,358.3,35673,0)
 ;;=F33.9^^189^2060^29
 ;;^UTILITY(U,$J,358.3,35673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35673,1,3,0)
 ;;=3^Major depressive disorder, recurrent, unspecified
 ;;^UTILITY(U,$J,358.3,35673,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,35673,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,35674,0)
 ;;=F05.^^189^2060^14
 ;;^UTILITY(U,$J,358.3,35674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35674,1,3,0)
 ;;=3^Delirium due to known physiological condition
 ;;^UTILITY(U,$J,358.3,35674,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,35674,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,35675,0)
 ;;=D70.9^^189^2060^32
 ;;^UTILITY(U,$J,358.3,35675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35675,1,3,0)
 ;;=3^Neutropenia, unspecified
 ;;^UTILITY(U,$J,358.3,35675,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,35675,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,35676,0)
 ;;=D69.6^^189^2060^42
 ;;^UTILITY(U,$J,358.3,35676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35676,1,3,0)
 ;;=3^Thrombocytopenia, unspecified
 ;;^UTILITY(U,$J,358.3,35676,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,35676,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,35677,0)
 ;;=D64.9^^189^2060^7
 ;;^UTILITY(U,$J,358.3,35677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35677,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,35677,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,35677,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,35678,0)
 ;;=D84.9^^189^2060^26
 ;;^UTILITY(U,$J,358.3,35678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35678,1,3,0)
 ;;=3^Immunodeficiency, unspecified
 ;;^UTILITY(U,$J,358.3,35678,1,4,0)
 ;;=4^D84.9
 ;;^UTILITY(U,$J,358.3,35678,2)
 ;;=^5002441
 ;;^UTILITY(U,$J,358.3,35679,0)
 ;;=E66.9^^189^2060^33
 ;;^UTILITY(U,$J,358.3,35679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35679,1,3,0)
 ;;=3^Obesity, unspecified
 ;;^UTILITY(U,$J,358.3,35679,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,35679,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,35680,0)
 ;;=E88.01^^189^2060^6
 ;;^UTILITY(U,$J,358.3,35680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35680,1,3,0)
 ;;=3^Alpha-1-antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,35680,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,35680,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,35681,0)
 ;;=E87.5^^189^2060^22
 ;;^UTILITY(U,$J,358.3,35681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35681,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,35681,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,35681,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,35682,0)
 ;;=E86.0^^189^2060^13
 ;;^UTILITY(U,$J,358.3,35682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35682,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,35682,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,35682,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,35683,0)
 ;;=E83.42^^189^2060^24
 ;;^UTILITY(U,$J,358.3,35683,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI21K
